Tag: Parkinson’s
Subcutaneous Infusion of Levodopa-Carbidopa Beneficial for Parkinson Disease
Infusion increases on time without troublesome dyskinesia and reduces daily off time
Lixisenatide Reduces Motor Disability Progression in Parkinson Disease
Lixisenatide results in less progression of motor disability than placebo at 12 months for individuals with early Parkinson disease
AAN: Three Pesticides Linked to Risk for Parkinson Disease
Highest versus lowest decile of application of simazine, lindane, atrazine linked to increased relative risks for Parkinson disease
QOL Outcomes Stable With Neurostimulation in Parkinson Disease
PDQ-8 and ADL worsened in standard-of-care medication group, remained stable in stimulation group
Cardiac 18F-Dopamine PET Can Predict Lewy Body Diseases
All nine LBD+ participants had low 18F-dopamine-derived radioactivity before or at the time of diagnosis of central LBD
Tai Chi Shows Benefits for Parkinson Disease Patients
Improvements seen in motor and nonmotor symptoms, reductions in disability and complications
Loneliness Increases Risk for Incident Parkinson Disease
Findings persist across demographic groups and independent of depression and other prominent risk factors, including genetic risk
AI Tool May Aid Remote Assessment of Parkinson Symptom Severity
Performance better than certified rater but not quite as good as expert neurologists
Alzheimer, Parkinson Disease Share Protective Association at HLA Locus
Protective HLA-DRB1*04 subtypes bind strongly to aggregation-prone tau PHF6 sequence when acetylated at K311
Specific GI Syndromes Linked to Parkinson Disease
Gastroparesis, dysphagia, constipation, and IBS without diarrhea are associated with PD in case-control, cohort analyses
